dauricine has been researched along with Colonic Neoplasms in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Du, B; Guo, X; Li, C; Li, D; Liu, B; Liu, M; Luo, J; Wang, L; Wang, X; Wu, H; Yang, Z; Yi, Z; Zhai, C | 1 |
1 other study(ies) available for dauricine and Colonic Neoplasms
Article | Year |
---|---|
Dauricine induces apoptosis, inhibits proliferation and invasion through inhibiting NF-kappaB signaling pathway in colon cancer cells.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Benzylisoquinolines; Caspases; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Colonic Neoplasms; Extracellular Signal-Regulated MAP Kinases; Gene Expression Regulation, Neoplastic; Humans; I-kappa B Proteins; Mice; Mitogen-Activated Protein Kinase 8; Mitogen-Activated Protein Kinase 9; Molecular Structure; Neoplasm Invasiveness; Neoplasm Transplantation; NF-kappa B; NF-KappaB Inhibitor alpha; p38 Mitogen-Activated Protein Kinases; Poly(ADP-ribose) Polymerases; Signal Transduction; Tetrahydroisoquinolines | 2010 |